Honig MG, Del Mar NA, Henderson DL, O'Neal D, et al. Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast. Exp Eye Res 2022 Feb 7:108966. doi: 10.1016/j.exer.2022.108966.
PMID: 35143834